Ronixone-S 1.5 Injection
Marketer
Ronish Bioceuticals
Salt Composition
Ceftriaxone (1000mg) + Sulbactam (500mg)
Overview Ronixone-S 1.5 Injection
Combiflox 1.5 Injection, a dual-action antibiotic, combats diverse bacterial infections by inhibiting microbial proliferation and preventing infection spread. Administration must be solely under a physician's guidance; strict adherence to the prescribed dosage schedule is crucial, completing the entire course regardless of symptom improvement. Premature cessation may compromise treatment efficacy. Potential side effects include nausea, vomiting, diarrhea, and digestive upset. Report any worsening symptoms or allergic reactions (rash, itching, swelling, respiratory difficulty) immediately. Inform your doctor of all current medications, especially if pregnant or breastfeeding, before commencing treatment. Alcohol consumption should be avoided due to potential increased drowsiness. While typically non-impairing, driving should be avoided if drowsiness or dizziness occurs. Rest, proper nutrition, and hydration are vital for optimal recovery. Your doctor may order blood tests and other assessments to monitor the medicine's impact.
Uses of Ronixone-S 1.5 Injection
Infections caused by bacteria
Major Benefits of Ronixone-S 1.5 Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Ronixone-S 1.5 Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Ronixone-S 1.5 Injection:
The medication will be administered by your physician or their qualified assistant; self-medication is strongly discouraged.
How Ronixone-S 1.5 Injection works:
Ronixone-S 1.5 Injection unites Ceftriaxone, a crucial antibiotic, with Sulbactam, a beta-lactamase inhibitor. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, a process vital for bacterial viability. Sulbactam's role is to counteract bacterial resistance mechanisms, thereby optimizing Ceftriaxone's antibacterial efficacy.
SAFETY ADVICE
AlcoholSAFE
Alcohol consumption alongside Ronixone-S 1.5 Injection does not produce adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Ronixone-S 1.5 is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no harm to offspring; nevertheless, data from human trials remain scarce.
Breast feedingCAUTION
The administration of Ronixone-S 1.5 Injection to breastfeeding mothers requires careful consideration. Mothers should discontinue breastfeeding throughout their treatment and until the medication is fully cleared from their system.
DrivingUNSAFE
Administration of Ronixone-S 1.5 Injection can lead to reduced awareness, visual impairment, drowsiness, and dizziness. Driving should be avoided if any of these effects are experienced.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Ronixone-S 1.5 Injection to individuals with renal impairment. Physician consultation is recommended.
LiverCAUTION
Exercise caution when administering Ronixone-S 1.5 Injection to individuals with severe hepatic impairment; dosage modification may be necessary. Consult a physician for guidance. Dosage alteration for Ronixone-S 1.5 Injection is unnecessary in patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Ronixone-S 1.5 Injection :
Omit a Ronixone-S 1.5 Injection dose? Seek medical advice immediately.
Facts to Know About Ronixone-S 1.5 Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |

